Intravenous administration of daunorubicin is an FDA-approved drug for the treatment of oncologic malignanciesDaunorubicin induces cell death and suppresses pulmonary artery constriction in a hypoxia-induced animal model of pulmonary hypertensionDaunorubicin mediated suppression of pulmonary artery .....
[更多]
Reduces chronic conditions assocated with menopause with an improved safety profile
[更多]
This invention provides an engineered degradation-resistant HOXB4 protein, materials and methods to produce it, and methods to use this recombinant protein for the ex vivo expansion of hematopoietic stem cells.
[更多]
Personalized treatment based on a patient’s individual brain anatomyMore specific targeting for brain therapiesIncreased safetyDecreased complications associated with neurosurgical treatments
[更多]
| |< <- | [3121] [3122] [3123] [3124] [3125] [3126] [3127] [3128] [3129] [3130] [3131] |
